This brand name is authorized in United States
The drug MAVYRET contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Pibrentasvir
UNII 2WU922TK3L - PIBRENTASVIR
|
|
Pibrentasvir is a pan-genotypic inhibitor of HCV nonstructural protein 5A (NS5A), which is essential for viral RNA replication and virion assembly. |
|
2
Glecaprevir
UNII K6BUU8J72P - GLECAPREVIR
|
|
|
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: US | FDA, National Drug Code | Identifier(s): 0074-2625 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
